Institute of Neuroradiology, Goethe-University Hospital Frankfurt, Schleusenweg 2-16, 60528, Frankfurt, Germany.
Institute of Biostatistics and mathematical Modelling, Goethe University, Theodor-Stern-Kai 7, 60590, Frankfurt, Germany.
Clin Neuroradiol. 2019 Mar;29(1):117-123. doi: 10.1007/s00062-017-0628-2. Epub 2017 Sep 30.
Low-dose cranial computed tomography (LD-CCT) based on iterative reconstruction has been shown to have sufficient image quality to assess cerebrospinal fluid spaces (CSF) and midline structures but not to exclude subtle parenchymal pathologies. Patients without focal neurological deficits often undergo CCT before lumbar puncture (LP) to exclude contraindications to LP including brain herniation or increased CSF pressure. We performed LD-CCT to assess if image quality is appropriate for this indication.
A total of 58 LD-CCT (220 mA/120 kV) of patients before LP were retrospectively evaluated and compared to 79 normal standard dose cranial computed tomography (SD-CCT) (350 mA/120 kV). Iterative reconstruction used for both dose levels was increased by one factor for LD-CCT. We assessed the signal-to-noise (SNR) and contrast-to-noise ratio (CNR), the dose estimates and scored diagnostic image quality by two raters independently. Significance level was set at p < 0.05.
The inner and outer CSF spaces except the sulci were equally well depicted by the LD-CCT and SD-CCT; however, depiction of the subtle density differences of the brain parenchyma and the sulci was significantly worse in the LD-CCT (p < 0.0001). The SNR in the gray matter (9.35 vs. 10.61, p < 0.05) and white matter (7.23 vs. 8.15, p < 0.001) were significantly lower in LD-CCT than in SD-CCT with significantly lower dose estimates (1.04 vs. 1.69 mSv, respectively p < 0.0001).
The use of LD-CCT with a dose reduction of almost 50% is sufficient to exclude contraindications to LP; however, LD-CCT cannot exclude subtle parenchymal pathologies. Therefore, in patients with suspected parenchymal pathology, SD-CCT is still the method of choice.
基于迭代重建的低剂量颅脑 CT(LD-CCT)已被证明具有足够的图像质量来评估脑脊液(CSF)和中线结构,但不能排除细微的实质病变。没有局灶性神经功能缺损的患者通常在腰椎穿刺(LP)前进行 CCT,以排除 LP 的禁忌症,包括脑疝或 CSF 压力增加。我们进行 LD-CCT 以评估其在该适应症下的图像质量是否合适。
回顾性评估了 58 例 LP 前 LD-CCT(220mA/120kV)患者,并与 79 例正常标准剂量颅脑 CT(SD-CCT)(350mA/120kV)进行比较。两种剂量水平均使用增加一个因子的迭代重建。我们由两位评分者独立评估信号噪声比(SNR)和对比噪声比(CNR)、剂量估计值和诊断图像质量评分。显著性水平设为 p<0.05。
除脑沟外,LD-CCT 和 SD-CCT 同样可以很好地显示内、外 CSF 空间;然而,LD-CCT 对脑实质和脑沟细微密度差异的显示明显更差(p<0.0001)。灰质(9.35 与 10.61,p<0.05)和白质(7.23 与 8.15,p<0.001)的 SNR 明显更低,LD-CCT 的剂量估计值明显更低(1.04 与 1.69mSv,p<0.0001)。
使用剂量降低近 50%的 LD-CCT 足以排除 LP 的禁忌症;然而,LD-CCT 不能排除细微的实质病变。因此,在疑似实质病变的患者中,SD-CCT 仍然是首选方法。